Skip to main content
Top
Published in: Pediatric Cardiology 7/2022

05-04-2022 | Patent Ductus Arteriosus | Original Article

Palliation Strategy to Achieve Complete Repair in Symptomatic Neonates with Tetralogy of Fallot

Authors: Mark A. Law, Andrew C. Glatz, Jennifer C. Romano, Paul J. Chai, Christopher E. Mascio, Christopher J. Petit, Courtney E. McCracken, Michael S. Kelleman, George T. Nicholson, Jeffery J. Meadows, Jeffrey D. Zampi, Shabana Shahanavaz, Sarosh P. Batlivala, Joelle Pettus, Amy L. Pajk, Kristal M. Hock, Bryan H. Goldstein, Athar M. Qureshi, The Congenital Cardiac Research Collaborative (CCRC) Investigators

Published in: Pediatric Cardiology | Issue 7/2022

Login to get access

Abstract

Neonates with symptomatic tetralogy of Fallot (sTOF) may undergo palliations with varying physiology, namely systemic to pulmonary artery connections (SPC) or right ventricular outflow tract interventions (RVOTI). A comparison of palliative strategies based on the physiology created is lacking. Consecutive sTOF neonates undergoing SPC or RVOTI from 2005–2017 were reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was survival with successful complete repair (CR) by 18 months. A variety of secondary outcomes were assessed including overall survival, hospitalization-related comorbidities, and interstage reinterventions. Propensity score adjustment was utilized to compare treatment strategies. The cohort included 252 SPC (surgical shunt = 226, ductus arteriosus stent = 26) and 68 RVOTI (balloon pulmonary valvuloplasty = 48, RVOT stent = 11, RVOT patch = 9) patients. Genetic syndrome (29 [42.6%] v 75 [29.8%], p = 0.04), weight < 2.5 kg (28 [41.2%] v 68 [27.0%], p = 0.023), bilateral pulmonary artery Z-score < − 2 (19 [28.0%] v 36 [14.3%], p = 0.008), and pre-intervention antegrade flow (48 [70.6%] v 104 [41.3%], p < 0.001) were more common in RVOTI. Significant center differences were noted (p < 0.001). Adjusted survival to CR by 18 months (HR = 0.87, 95% CI = 0.63–1.21, p = 0.41) and overall survival (HR = 2.08, 95% CI = 0.93–4.65, p = 0.074) were similar. RVOTI had increased interstage reintervention (HR = 2.15, 95% CI = 1.36–3.99, p = 0.001). Total anesthesia (243 [213, 277] v 328 [308, 351] minutes, p < 0.001) and cardiopulmonary bypass times (117 [103, 132] v 151 [143, 160] minutes, p < 0.001) favored RVOTI. In this multicenter comparison of physiologic palliation strategies for sTOF, survival to successful CR and overall survival were similar; however, reintervention burden was significantly higher in RVOTI.
Appendix
Available only for authorised users
Literature
5.
go back to reference Lizano santamaria RW, Gillespie MJ, Dori Y, Rome JJ, Glatz AC (2015) Palliative balloon pulmonary valvuloplasty for infants with unrestrictive ventricular septal defect or single ventricle associated with severe pulmonary stenosis. Catheter Cardiovasc Interv 86:829–833. https://doi.org/10.1002/ccd.26083CrossRefPubMed Lizano santamaria RW, Gillespie MJ, Dori Y, Rome JJ, Glatz AC (2015) Palliative balloon pulmonary valvuloplasty for infants with unrestrictive ventricular septal defect or single ventricle associated with severe pulmonary stenosis. Catheter Cardiovasc Interv 86:829–833. https://​doi.​org/​10.​1002/​ccd.​26083CrossRefPubMed
10.
go back to reference Bradley SM, Erdem CC, Hsia TY, Atz AM, Bandisode V, Ringewald JM (2008) Right ventricle-to-pulmonary artery shunt: alternative palliation in infants with inadequate pulmonary blood flow prior to two-ventricle repair. Ann Thorac Surg 86:183–188CrossRef Bradley SM, Erdem CC, Hsia TY, Atz AM, Bandisode V, Ringewald JM (2008) Right ventricle-to-pulmonary artery shunt: alternative palliation in infants with inadequate pulmonary blood flow prior to two-ventricle repair. Ann Thorac Surg 86:183–188CrossRef
13.
go back to reference Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey T, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM (2018) Comparison between patent ductus arteriosus stent and modified blalock-taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137:589–601. https://doi.org/10.1161/CIRCULATIONAHA.117.029987CrossRefPubMed Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey T, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM (2018) Comparison between patent ductus arteriosus stent and modified blalock-taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137:589–601. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​117.​029987CrossRefPubMed
15.
go back to reference Bentham JR, Kava NK, Harrison WJ, Shauq A, Kalantre A, Derrick G, Chen RH, Dhillon R, Taliotis D, Kang SL, Crossland D, Adesokan A, Hermuzi A, Kudumula V, Yong S, Noonan P, Hayes N, Stumper O, Thomason JDR (2018) Stenting versus modified Blalock-Taussig shunt in neonates with duct dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation 137:581–588. https://doi.org/10.1161/CIRCULATIONAHA.117.028972CrossRefPubMed Bentham JR, Kava NK, Harrison WJ, Shauq A, Kalantre A, Derrick G, Chen RH, Dhillon R, Taliotis D, Kang SL, Crossland D, Adesokan A, Hermuzi A, Kudumula V, Yong S, Noonan P, Hayes N, Stumper O, Thomason JDR (2018) Stenting versus modified Blalock-Taussig shunt in neonates with duct dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation 137:581–588. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​117.​028972CrossRefPubMed
17.
go back to reference Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P (2011) Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 92:642–651 (discussion 51–2)CrossRef Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P (2011) Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 92:642–651 (discussion 51–2)CrossRef
18.
go back to reference Godart F, Qureshi SA, Simha A, Deverall PB, Anderson DR, Baker EJ, Tynan M (1998) Effects of modified and classic Blalock-Taussig shunts on the pulmonary arterial tree. Ann Thorac Surg 66:512–7 (discussion 8)CrossRef Godart F, Qureshi SA, Simha A, Deverall PB, Anderson DR, Baker EJ, Tynan M (1998) Effects of modified and classic Blalock-Taussig shunts on the pulmonary arterial tree. Ann Thorac Surg 66:512–7 (discussion 8)CrossRef
19.
go back to reference Goldstein BH, Petit CJ, Qureshi AM, McCracken CE, Kelleman MS, Nicholson GT, Law MA, Meadows JJ, Zampi JD, Shabanavaz S, Mascio CE, Chai PJ, Romano JC, Batlivala SP, Maskatia SA, Asztalos IB, Kamsheh AM, Healan SJ, Smith JD, Ligon RA, Pettus JA, Juma S, Raulston JEB, Hock KM, Pajk AL, Eilers LF, Khan HQ, Merritt TC, Canter M, Jerugensen S, Rinderknecht FA, Bauser-Heaton H, Glatz AC (2021) Comparison of management strategies for neonates with symptomatic tetralogy of Fallot. J Am Coll Cardiol 77:1093–1106. https://doi.org/10.1016/j.jacc.2020.12.048CrossRefPubMedPubMedCentral Goldstein BH, Petit CJ, Qureshi AM, McCracken CE, Kelleman MS, Nicholson GT, Law MA, Meadows JJ, Zampi JD, Shabanavaz S, Mascio CE, Chai PJ, Romano JC, Batlivala SP, Maskatia SA, Asztalos IB, Kamsheh AM, Healan SJ, Smith JD, Ligon RA, Pettus JA, Juma S, Raulston JEB, Hock KM, Pajk AL, Eilers LF, Khan HQ, Merritt TC, Canter M, Jerugensen S, Rinderknecht FA, Bauser-Heaton H, Glatz AC (2021) Comparison of management strategies for neonates with symptomatic tetralogy of Fallot. J Am Coll Cardiol 77:1093–1106. https://​doi.​org/​10.​1016/​j.​jacc.​2020.​12.​048CrossRefPubMedPubMedCentral
20.
go back to reference Petit CJ, Qureshi AM, Glatz AC, McCracken CE, Kelleman M, Nicholson GT, Meadows JJ, Shahanavaz S, Zampi JD, Law MA, Pettus JA, Goldstein BH (2019) Comprehensive comparative outcomes in children with congenital heart disease: the rationale for the congenital catheterization research collaborative. Congenit Heart Dis 14:341–349. https://doi.org/10.1111/chd.12737CrossRefPubMed Petit CJ, Qureshi AM, Glatz AC, McCracken CE, Kelleman M, Nicholson GT, Meadows JJ, Shahanavaz S, Zampi JD, Law MA, Pettus JA, Goldstein BH (2019) Comprehensive comparative outcomes in children with congenital heart disease: the rationale for the congenital catheterization research collaborative. Congenit Heart Dis 14:341–349. https://​doi.​org/​10.​1111/​chd.​12737CrossRefPubMed
21.
go back to reference Pettus JA, Pajk AL, Glatz AC, Petit CJ, Goldstein BH, Qureshi AM, Nicholson GT, Meadows JJ, Zampi JD, Law MA, Shahanavaz S, Kelleman MS, McCracken CM, Congenital Cardiac Research Collaborative (2021) Data quality methods through remote source data verification auditing: results from the Congenital Cardiac Research Collaborative. Cardiol Young 31:1829–1834. https://doi.org/10.1017/S1047951121000974CrossRefPubMed Pettus JA, Pajk AL, Glatz AC, Petit CJ, Goldstein BH, Qureshi AM, Nicholson GT, Meadows JJ, Zampi JD, Law MA, Shahanavaz S, Kelleman MS, McCracken CM, Congenital Cardiac Research Collaborative (2021) Data quality methods through remote source data verification auditing: results from the Congenital Cardiac Research Collaborative. Cardiol Young 31:1829–1834. https://​doi.​org/​10.​1017/​S104795112100097​4CrossRefPubMed
22.
go back to reference Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M, Ando M, Takao A (1984) A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 88:610–619CrossRef Nakata S, Imai Y, Takanashi Y, Kurosawa H, Tezuka K, Nakazawa M, Ando M, Takao A (1984) A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow. J Thorac Cardiovasc Surg 88:610–619CrossRef
23.
go back to reference Meadows JJ, Qureshi AM, Goldstein BH, Petit CJ, McCracken CE, Kelleman MS, Aggarwal V, bauser-Heaton H, Combs CS, Gartenberg AJ, Ligon RA, Nicholson GT, Galtz AC (2019) Comparison of Outcomes at Time of Superior Cavopulmonary Connection Between Single Ventricle Patients With Ductal-Dependent Pulmonary Blood Flow Initially Palliated With Either Blalock-Taussig Shunt or Ductus Arteriosus Stent: Results From the Congenital Catheterization Research Collaborative. Circ Cardiovasc Interv 12:e008110. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008110CrossRefPubMed Meadows JJ, Qureshi AM, Goldstein BH, Petit CJ, McCracken CE, Kelleman MS, Aggarwal V, bauser-Heaton H, Combs CS, Gartenberg AJ, Ligon RA, Nicholson GT, Galtz AC (2019) Comparison of Outcomes at Time of Superior Cavopulmonary Connection Between Single Ventricle Patients With Ductal-Dependent Pulmonary Blood Flow Initially Palliated With Either Blalock-Taussig Shunt or Ductus Arteriosus Stent: Results From the Congenital Catheterization Research Collaborative. Circ Cardiovasc Interv 12:e008110. https://​doi.​org/​10.​1161/​CIRCINTERVENTION​S.​119.​008110CrossRefPubMed
24.
25.
go back to reference Rhodes J, O’Brien S, Patel H, Cao QL, Banerjee A, Hijazi ZM (2000) Palliative balloon pulmonary valvuloplasty in tetralogy of fallot: echocardiographic predictors of successful outcome. J Invasive Cardiol 12:448–451PubMed Rhodes J, O’Brien S, Patel H, Cao QL, Banerjee A, Hijazi ZM (2000) Palliative balloon pulmonary valvuloplasty in tetralogy of fallot: echocardiographic predictors of successful outcome. J Invasive Cardiol 12:448–451PubMed
26.
go back to reference Quandt D, Penford G, Ramchandani B, Bhole V, Mehta C, Stumper O (2017) Stenting of the right ventricular outflow tract as primary palliation for Fallot-type lesions. J Congenit Cardiol 1:3CrossRef Quandt D, Penford G, Ramchandani B, Bhole V, Mehta C, Stumper O (2017) Stenting of the right ventricular outflow tract as primary palliation for Fallot-type lesions. J Congenit Cardiol 1:3CrossRef
28.
go back to reference Qureshi AM, Caldarone CA, Romano JC, Chai PJ, Mascio CE, Glatz AC, Petit CJ, McCracken CE, Kelleman MS, Nicholson GT, Meadows JJ, Zampi JD, Shabanavaz S, Law MA, Batlivala SP, Goldstein BH (2021) Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight<2.5 kg. J Thorac Cardiovasc Surg. https://doi.org/10.1016/j.jtcvs.2021.01.100CrossRefPubMed Qureshi AM, Caldarone CA, Romano JC, Chai PJ, Mascio CE, Glatz AC, Petit CJ, McCracken CE, Kelleman MS, Nicholson GT, Meadows JJ, Zampi JD, Shabanavaz S, Law MA, Batlivala SP, Goldstein BH (2021) Comparison of management strategies for neonates with symptomatic tetralogy of Fallot and weight<2.5 kg. J Thorac Cardiovasc Surg. https://​doi.​org/​10.​1016/​j.​jtcvs.​2021.​01.​100CrossRefPubMed
Metadata
Title
Palliation Strategy to Achieve Complete Repair in Symptomatic Neonates with Tetralogy of Fallot
Authors
Mark A. Law
Andrew C. Glatz
Jennifer C. Romano
Paul J. Chai
Christopher E. Mascio
Christopher J. Petit
Courtney E. McCracken
Michael S. Kelleman
George T. Nicholson
Jeffery J. Meadows
Jeffrey D. Zampi
Shabana Shahanavaz
Sarosh P. Batlivala
Joelle Pettus
Amy L. Pajk
Kristal M. Hock
Bryan H. Goldstein
Athar M. Qureshi
The Congenital Cardiac Research Collaborative (CCRC) Investigators
Publication date
05-04-2022
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 7/2022
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-022-02886-0

Other articles of this Issue 7/2022

Pediatric Cardiology 7/2022 Go to the issue